Predictive role of tumor microenvironment components and stem cell markers in vulvar squamous cell carcinoma

Background. Vulvar cancer remains a rare but aggressive pathology with a high percentage of advanced cases at the time of diagnosis. Understanding the role of the tumor microenvironment is critically important for predicting disease progression and developing new therapeutic strategies. Aim. To evaluate the prognostic significance of expression of stemness (ALDH1, CD133), matrix remodeling (MMP-2, TIMP-2) and immunosuppression (CD68, CD206, FoxP3) markers in tumor cells and stroma of vulvar squamous cell carcinoma. Materials and methods. A retrospective immunohistochemical study was conducted on surgical specimens from 56 patients with confirmed vulvar squamous cell carcinoma (stage I: n = 20; stage II: n = 26; recurrences: n = 10). A semi-quantitative analysis of marker expression was performed, assessing associations with clinical and morphological parameters (stage, invasion depth). Results. Vulvar cancer progression (stage II, invasion 4 mm) was associated with an increase in the stem cell pool (ALDH1+ in the stroma, CD133+ in the tumor); an increase in MMP-2 expression (p = 0.01); accumulation of M2 macrophages (CD206+) and regulatory T cells (FoxP3+) in the stroma, with levels 4 times higher than in the parenchyma. Recurrences were characterized by a profile similar to early stages but with dominance of the M2 phenotype in the stroma ( 50 %) and a higher level of CD133+ expression. Conclusion. Stroma-dependent immunosuppression and stem cell activation are key drivers of vulvar cancer progression. The findings support the potential of targeted therapy directed at tumor microenvironment components.

Authors

Institutions

Publication Details

Journal
MD-Onco
Published
2026-11-17
DOI
https://doi.org/10.17650/2782-3202-2026-6-3-29-33
Primary Topic
Genital Health and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Predictive role of tumor microenvironment components and stem cell markers in vulvar squamous cell carcinoma

Nina M. Abdullaeva, Ekaterina V. Verenikina, Elena Petrovna Ulianova, E. Yu. Zlatnik et al.
MD-Onco
Genital Health and Disease
article

Predictive role of tumor microenvironment components and stem cell markers in vulvar squamous cell carcinoma

Nina M. Abdullaeva, Ekaterina V. Verenikina, Elena Petrovna Ulianova, E. Yu. Zlatnik, Меньшенина Валерия Алексеевна, Адамян Алла Оганесовна, Z. V. Verenikina, S. A. Kornienko
article en

Abstract

Background. Vulvar cancer remains a rare but aggressive pathology with a high percentage of advanced cases at the time of diagnosis. Understanding the role of the tumor microenvironment is critically important for predicting disease progression and developing new therapeutic strategies. Aim. To evaluate the prognostic significance of expression of stemness (ALDH1, CD133), matrix remodeling (MMP-2, TIMP-2) and immunosuppression (CD68, CD206, FoxP3) markers in tumor cells and stroma of vulvar squamous cell carcinoma. Materials and methods. A retrospective immunohistochemical study was conducted on surgical specimens from 56 patients with confirmed vulvar squamous cell carcinoma (stage I: n = 20; stage II: n = 26; recurrences: n = 10). A semi-quantitative analysis of marker expression was performed, assessing associations with clinical and morphological parameters (stage, invasion depth). Results. Vulvar cancer progression (stage II, invasion 4 mm) was associated with an increase in the stem cell pool (ALDH1+ in the stroma, CD133+ in the tumor); an increase in MMP-2 expression (p = 0.01); accumulation of M2 macrophages (CD206+) and regulatory T cells (FoxP3+) in the stroma, with levels 4 times higher than in the parenchyma. Recurrences were characterized by a profile similar to early stages but with dominance of the M2 phenotype in the stroma ( 50 %) and a higher level of CD133+ expression. Conclusion. Stroma-dependent immunosuppression and stem cell activation are key drivers of vulvar cancer progression. The findings support the potential of targeted therapy directed at tumor microenvironment components.

MD-OncoVol. 6(3)
Rostov State Medical University (RU), Pirogov Russian National Research Medical University (RU), Ministry of Health of the Russian Federation (RU)
Genital Health and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon